Article Details

Biotech MAIA Secures EU Patent for Dual-Action Cancer Treatment - Stock Titan

Retrieved on: 2025-08-13 13:03:46

Tags for this article:

Click the tags to see associated articles and topics

Biotech MAIA Secures EU Patent for Dual-Action Cancer Treatment - Stock Titan. View article details on hiswai:

Excerpt

Novel therapy targets both telomeres and immune response in cancer cells, showing improved specificity over existing treatments.

Article found on: www.stocktitan.net

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo